resolutionmini

 

 

mise à jour du
18 mars 2010
Neuroscience
1994;58(4):799-805
The angiotensin converting enzyme inhibitors
captopril and enalapril inhibit apomorphine-induced
oral stereotypy in the rat
Banks RJ, Mozley L, Dourish CT.
Department of Psychology, University of Sheffield, U.K.

Chat-logomini

 
The possible functional interaction between angiotensin and dopamine mechanisms in the rat was investigated by examining the effects of the angiotensin converting enzyme inhibitors captopril and enalapril on apomorphine-induced stereotypy. Apomorphine-induced behaviour was observed, and recorded using a keypad linked to a microcomputer. In agreement with previous findings, low doses of apomorphine induced a syndrome of vacuous mouth movements, penile grooming, yawning and immobility whereas at higher doses the yawning syndrome disappeared to be replaced with sniffing, licking and gnawing.
 
Two antagonism studies were carried out. In the first the effects of captopril on apomorphine-induced behaviour were compared with those of the classical neuroleptic haloperidol, and in the second dose-response curves for the effects of captopril and enalapril on apomorphine-induced behaviour were determined. Captopril had no effect on the apomorphine-induced yawning syndrome whereas this was blocked by haloperidol. In contrast, both captopril and haloperidol blocked oral stereotypy (licking and gnawing) induced by apomorphine but had no effect on sniffing induced by the dopamine agonist. Selective blockade of apomorphine-induced oral stereotypy by angiotensin converting enzyme inhibition was confirmed in the second study in which both captopril and enalapril were observed to antagonize apomorphine-induced gnawing.
 
The inhibition of apomorphine-induced gnawing by enalapril correlated with inhibition of brain angiotensin converting enzyme, but not lung angiotensin converting enzyme, by the drug as assessed by ex vivo penetration studies.
 
These data suggest that angiotensin converting enzyme inhibition modulates the expression of apomorphine-induced oral stereotypy, a response that is thought to be mediated by postsynaptic dopamine receptors. In contrast, the yawning syndrome induced by low doses of apomorphine which is thought to be due to selective stimulation of dopamine autoreceptors is unaffected by the angiotensin converting enzyme inhibitors. Thus the pharmacological interaction between inhibition of brain angiotensin converting enzyme and blockade of apomorphine-induced oral stereotypy probably occurs at postsynaptic dopamine receptors or at downstream sites innervated by striatal neurones (e.g., substantia nigraor superior colliculus).
 

 

-Banks RJ, Mozley L, Dourish CT. The angiotensin converting enzyme inhibitors captopril and enalapril inhibit apomorphine-induced oral stereotypy in the rat. Neuroscience. 1994;58(4):799-805  
-Stoessl AJ, Dourish CT, Iversen SD Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra Psychopharmacol; 1987; 93; 336-342
-Stoessl AJ Effects of ageing on the behavioural responses to dopamine agonists: decreased yawning and locomotion, but increased stereotypy Brain Research 1989; 495; 20-30
-Stoessl AJ, Dourish CT, Iversen SD The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation. Psychopharmacology (Berl). 1988; 95; 4; 502-506
-Cooper SJ; Dourish CT Neural basis of drug induced yawning in neurobiology of stereotyped behaviour Oxford ed 1990
-Cooper SJ, Rusk IN, Barber DJ. Yawning Induced by the Selective Dopamine D2 Agonist N-0437 is Blocked by the Selective Doparnine Autoreceptor Antagonist (+)-UH 232. Physiol Behav. 1989;45:1263-1266
-Dourish CT, SJ Cooper Yawning elicited by sytemic and intrastriatal injection of piribedil and apomorphine in the rat Pyschopharmacology 1985; 86; 175-181
-Dourish CT, PH Hutson Bilateral lesions of the striatum induced with 6-hydroxydopamine abolish apomorphine-induced yawning in rats Neuropharmacology 1985; 24; 11; 1051-1055
-Collins G, JM Witkin et al Dopamine agonist-induced yawning in rats: a dopamine d3 receptor mediated behavior J Pharmacol Exp Ther 2005
 
Tous les travaux de MR Melis & A Argiolas 
Tous les travaux de M Eguibar & G Holmgren